$AXSM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Axsome Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Axsome Therapeutics, Inc.. Get notifications about new insider transactions in Axsome Therapeutics, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Buy | P | 58.15 | 500 | 29,075 | 420,998 | 420.5 K to 421 K (+0.12 %) |
| Mar 09 2021 | AXSM | Axsome Therapeutic ... | Pizzie Nick | Chief Financial Off ... | Option Exercise | A | 0.00 | 19,208 | 0 | 19,208 | |
| Mar 09 2021 | AXSM | Axsome Therapeutic ... | Pizzie Nick | Chief Financial Off ... | Option Exercise | A | 65.02 | 36,086 | 2,346,312 | 36,086 | |
| Mar 09 2021 | AXSM | Axsome Therapeutic ... | Saad Mark E | Director | Option Exercise | A | 65.02 | 1,241 | 80,690 | 1,241 | |
| Mar 09 2021 | AXSM | Axsome Therapeutic ... | Jacobson Mark L. | Chief Operating Off ... | Option Exercise | A | 0.00 | 22,163 | 0 | 22,163 | |
| Mar 09 2021 | AXSM | Axsome Therapeutic ... | Jacobson Mark L. | Chief Operating Off ... | Option Exercise | A | 65.02 | 41,638 | 2,707,303 | 41,638 | |
| Mar 09 2021 | AXSM | Axsome Therapeutic ... | TABUTEAU HERRIOT | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.00 | 51,715 | 0 | 51,715 | |
| Mar 09 2021 | AXSM | Axsome Therapeutic ... | TABUTEAU HERRIOT | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 65.02 | 97,155 | 6,317,018 | 97,155 | |
| Mar 09 2021 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Option Exercise | A | 65.02 | 1,201 | 78,089 | 1,201 | |
| Mar 09 2021 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 65.02 | 1,463 | 95,124 | 1,463 | |
| Aug 20 2020 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Gift | G | 0.00 | 397,998 | 0 | 397,998 | 0 to 398 K |
| Aug 20 2020 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Gift | G | 0.00 | 397,998 | 0 | 5,700 | 403.7 K to 5.7 K (-98.59 %) |
| Jun 30 2020 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Buy | P | 78.50 | 650 | 51,025 | 403,698 | 403 K to 403.7 K (+0.16 %) |
| Jun 30 2020 | AXSM | Axsome Therapeutic ... | Pizzie Nick | Chief Financial Off ... | Buy | P | 76.64 | 777 | 59,549 | 41,217 | 40.4 K to 41.2 K (+1.92 %) |
| Jun 05 2020 | AXSM | Axsome Therapeutic ... | Saad Mark E | Director | Option Exercise | A | 77.38 | 13,000 | 1,005,940 | 13,000 | |
| Jun 05 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 77.38 | 13,000 | 1,005,940 | 13,000 | |
| Jun 05 2020 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Option Exercise | A | 77.38 | 13,000 | 1,005,940 | 13,000 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | TABUTEAU HERRIOT | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.00 | 51,691 | 0 | 51,691 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | TABUTEAU HERRIOT | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 45.14 | 168,776 | 7,618,549 | 168,776 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | Pizzie Nick | Chief Financial Off ... | Option Exercise | A | 0.00 | 18,645 | 0 | 18,645 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | Pizzie Nick | Chief Financial Off ... | Option Exercise | A | 45.14 | 60,880 | 2,748,123 | 60,880 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | Jacobson Mark L. | Chief Operating Off ... | Option Exercise | A | 0.00 | 18,645 | 0 | 18,645 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | Jacobson Mark L. | Chief Operating Off ... | Option Exercise | A | 45.14 | 60,880 | 2,748,123 | 60,880 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | Marek David C | Chief Commercial Of ... | Option Exercise | A | 0.00 | 16,533 | 0 | 16,533 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | Marek David C | Chief Commercial Of ... | Option Exercise | A | 45.14 | 53,984 | 2,436,838 | 53,984 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 45.14 | 4,496 | 202,949 | 4,496 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | TABUTEAU HERRIOT | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.00 | 51,691 | 0 | 51,691 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | TABUTEAU HERRIOT | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 45.14 | 168,776 | 7,618,549 | 168,776 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Option Exercise | A | 45.14 | 3,308 | 149,323 | 3,308 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | Pizzie Nick | Chief Financial Off ... | Option Exercise | A | 0.00 | 18,645 | 0 | 18,645 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | Saad Mark E | Director | Option Exercise | A | 45.14 | 3,789 | 171,035 | 3,789 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | Pizzie Nick | Chief Financial Off ... | Option Exercise | A | 45.14 | 60,880 | 2,748,123 | 60,880 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | Jacobson Mark L. | Chief Operating Off ... | Option Exercise | A | 0.00 | 18,645 | 0 | 18,645 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | Jacobson Mark L. | Chief Operating Off ... | Option Exercise | A | 45.14 | 60,880 | 2,748,123 | 60,880 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | Marek David C | Chief Commercial Of ... | Option Exercise | A | 0.00 | 16,533 | 0 | 16,533 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | Marek David C | Chief Commercial Of ... | Option Exercise | A | 45.14 | 53,984 | 2,436,838 | 53,984 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 45.14 | 4,496 | 202,949 | 4,496 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Option Exercise | A | 45.14 | 3,308 | 149,323 | 3,308 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | Saad Mark E | Director | Option Exercise | A | 45.14 | 3,789 | 171,035 | 3,789 | |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 12.95 | 34,866 | 451,515 | 0 | |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 4.95 | 11,000 | 54,450 | 0 | |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 8.02 | 5,193 | 41,648 | 0 | |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 9.00 | 9,127 | 82,143 | 0 | |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 12.95 | 34,866 | 451,515 | 116,806 | 81.9 K to 116.8 K (+42.55 %) |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 4.95 | 11,000 | 54,450 | 81,940 | 70.9 K to 81.9 K (+15.51 %) |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 8.02 | 5,193 | 41,648 | 70,940 | 65.7 K to 70.9 K (+7.90 %) |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 9.00 | 9,127 | 82,143 | 65,747 | 56.6 K to 65.7 K (+16.12 %) |
| Oct 15 2019 | AXSM | Axsome Therapeutic ... | TABUTEAU HERRIOT | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 17.61 | 68,837 | 1,212,220 | 68,837 | |
| Oct 15 2019 | AXSM | Axsome Therapeutic ... | TABUTEAU HERRIOT | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 17.61 | 68,837 | 1,212,220 | 68,837 | |
| Oct 15 2019 | AXSM | Axsome Therapeutic ... | Pizzie Nick | Chief Financial Off ... | Option Exercise | A | 17.61 | 25,813 | 454,567 | 25,813 | |
| Oct 15 2019 | AXSM | Axsome Therapeutic ... | Marek David C | Chief Commercial Of ... | Option Exercise | A | 17.61 | 25,813 | 454,567 | 25,813 | |
| Oct 15 2019 | AXSM | Axsome Therapeutic ... | Pizzie Nick | Chief Financial Off ... | Option Exercise | A | 17.61 | 25,813 | 454,567 | 25,813 | |
| Oct 15 2019 | AXSM | Axsome Therapeutic ... | Marek David C | Chief Commercial Of ... | Option Exercise | A | 17.61 | 25,813 | 454,567 | 25,813 | |
| Sep 30 2019 | AXSM | Axsome Therapeutic ... | Pizzie Nick | Chief Financial Off ... | Buy | P | 24.80 | 2,180 | 54,064 | 40,440 | 38.3 K to 40.4 K (+5.70 %) |
| Sep 06 2019 | AXSM | Axsome Therapeutic ... | Marek David C | Chief Commercial Of ... | Option Exercise | A | 24.28 | 125,000 | 3,035,000 | 125,000 | |
| Jul 05 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 3.45 | 13,000 | 44,850 | 0 | |
| Jul 05 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 2.85 | 39,948 | 113,852 | 0 | |
| Jul 05 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 3.67 | 3,672 | 13,476 | 7,344 | |
| Jul 05 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 3.45 | 13,000 | 44,850 | 56,620 | 43.6 K to 56.6 K (+29.80 %) |
| Jul 05 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 2.85 | 39,948 | 113,852 | 43,620 | 3.7 K to 43.6 K (+1,087.91 %) |
| Jul 05 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 3.67 | 3,672 | 13,476 | 3,672 | 0 to 3.7 K |
| Jun 27 2019 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Buy | P | 23.10 | 15,800 | 364,980 | 668,848 | 653 K to 668.8 K (+2.42 %) |
| Jun 27 2019 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Buy | P | 23.25 | 400 | 9,300 | 653,048 | 652.6 K to 653 K (+0.06 %) |
| Jun 12 2019 | AXSM | Axsome Therapeutic ... | Pizzie Nick | Chief Financial Off ... | Buy | P | 20.80 | 1,920 | 39,936 | 1,920 | 0 to 1.9 K |
| Jun 10 2019 | AXSM | Axsome Therapeutic ... | Saad Mark E | Director | Option Exercise | A | 22.03 | 13,000 | 286,390 | 13,000 | |
| Jun 10 2019 | AXSM | Axsome Therapeutic ... | POTTER MYRTLE S | Director | Option Exercise | A | 22.03 | 13,000 | 286,390 | 13,000 | |
| Jun 10 2019 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Option Exercise | A | 22.03 | 13,000 | 286,390 | 13,000 | |
| Jun 10 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 22.03 | 13,000 | 286,390 | 13,000 | |
| May 24 2019 | AXSM | Axsome Therapeutic ... | Saad Mark E | Director | Buy | P | 22.33 | 3,500 | 78,155 | 7,002 | 3.5 K to 7 K (+99.94 %) |
| May 15 2019 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Buy | P | 21.44 | 4,650 | 99,696 | 652,648 | 648 K to 652.6 K (+0.72 %) |
| Mar 21 2019 | AXSM | Axsome Therapeutic ... | TABUTEAU HERRIOT | Chief Executive Off ... | Option Exercise | A | 12.95 | 319,212 | 4,133,795 | 319,212 | |
| Mar 21 2019 | AXSM | Axsome Therapeutic ... | Saad Mark E | Director | Option Exercise | A | 12.95 | 29,387 | 380,562 | 29,387 | |
| Mar 21 2019 | AXSM | Axsome Therapeutic ... | Pizzie Nick | Chief Financial Off ... | Option Exercise | A | 12.95 | 75,102 | 972,571 | 75,102 | |
| Mar 21 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 12.95 | 34,866 | 451,515 | 34,866 | |
| Mar 21 2019 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Option Exercise | A | 12.95 | 25,652 | 332,193 | 25,652 | |
| Mar 21 2019 | AXSM | Axsome Therapeutic ... | Pizzie Nick | Chief Financial Off ... | Buy | P | 12.58 | 5,340 | 67,177 | 36,340 | 31 K to 36.3 K (+17.23 %) |
| Mar 21 2019 | AXSM | Axsome Therapeutic ... | Pizzie Nick | Chief Financial Off ... | Buy | P | 12.69 | 60 | 761 | 60 | 0 to 60 |
| Mar 21 2019 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Buy | P | 12.18 | 5,100 | 62,118 | 5,100 | 0 to 5.1 K |
| Jun 20 2018 | AXSM | Axsome Therapeutic ... | Pizzie Nick | Chief Financial Off ... | Buy | P | 3.10 | 30,600 | 94,860 | 31,000 | 400 to 31 K (+7,650.00 %) |
| Jun 20 2018 | AXSM | Axsome Therapeutic ... | Pizzie Nick | Chief Financial Off ... | Buy | P | 3.05 | 400 | 1,220 | 400 | 0 to 400 |
| Jun 05 2018 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Option Exercise | A | 3.45 | 13,000 | 44,850 | 13,000 | |
| Jun 05 2018 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 3.45 | 13,000 | 44,850 | 13,000 | |
| Jun 05 2018 | AXSM | Axsome Therapeutic ... | Saad Mark E | Director | Option Exercise | A | 3.45 | 13,000 | 44,850 | 13,000 | |
| Jun 05 2018 | AXSM | Axsome Therapeutic ... | POTTER MYRTLE S | Director | Option Exercise | A | 3.45 | 4,000 | 13,800 | 4,000 | |
| Jun 05 2018 | AXSM | Axsome Therapeutic ... | POTTER MYRTLE S | Director | Option Exercise | A | 3.45 | 13,000 | 44,850 | 13,000 | |
| May 29 2018 | AXSM | Axsome Therapeutic ... | Pizzie Nick | Chief Financial Off ... | Option Exercise | A | 3.50 | 132,000 | 462,000 | 132,000 | |
| Apr 05 2018 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 2.85 | 39,948 | 113,852 | 39,948 | |
| Apr 05 2018 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Option Exercise | A | 2.85 | 27,297 | 77,796 | 27,297 | |
| Apr 05 2018 | AXSM | Axsome Therapeutic ... | Saad Mark E | Director | Option Exercise | A | 2.85 | 32,602 | 92,916 | 32,602 | |
| Apr 05 2018 | AXSM | Axsome Therapeutic ... | TABUTEAU HERRIOT | Chief Executive Off ... | Option Exercise | A | 2.85 | 187,628 | 534,740 | 187,628 | |
| Aug 08 2017 | AXSM | Axsome Therapeutic ... | Golubieski John | Chief Financial Off ... | Option Exercise | A | 5.90 | 132,000 | 778,800 | 132,000 | |
| Jun 19 2017 | AXSM | Axsome Therapeutic ... | POTTER MYRTLE S | Director | Option Exercise | A | 4.10 | 8,197 | 33,608 | 8,197 | |
| Jun 19 2017 | AXSM | Axsome Therapeutic ... | POTTER MYRTLE S | Director | Option Exercise | A | 4.10 | 22,000 | 90,200 | 22,000 | |
| Mar 30 2017 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 4.95 | 35,194 | 174,210 | 0 | |
| Mar 30 2017 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 3.67 | 7,344 | 26,952 | 3,672 | |
| Mar 30 2017 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 4.95 | 35,194 | 174,210 | 46,912 | 11.7 K to 46.9 K (+300.34 %) |
| Mar 30 2017 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 3.67 | 7,344 | 26,952 | 11,718 | 4.4 K to 11.7 K (+167.90 %) |
| Mar 17 2017 | AXSM | Axsome Therapeutic ... | TABUTEAU HERRIOT | Chief Executive Off ... | Option Exercise | A | 4.95 | 149,000 | 737,550 | 149,000 | |
| Mar 17 2017 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 4.95 | 11,000 | 54,450 | 11,000 | |
| Mar 17 2017 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 4.95 | 35,194 | 174,210 | 35,194 | |
| Mar 17 2017 | AXSM | Axsome Therapeutic ... | Ames Constance | Vice President, Fin ... | Option Exercise | A | 4.95 | 25,000 | 123,750 | 25,000 | |
| Mar 17 2017 | AXSM | Axsome Therapeutic ... | Saad Mark E | Director | Option Exercise | A | 4.95 | 11,000 | 54,450 | 11,000 | |
| Mar 17 2017 | AXSM | Axsome Therapeutic ... | Saad Mark E | Director | Option Exercise | A | 4.95 | 31,346 | 155,163 | 31,346 | |
| Mar 17 2017 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Option Exercise | A | 4.95 | 11,000 | 54,450 | 11,000 | |
| Mar 17 2017 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Option Exercise | A | 4.95 | 26,456 | 130,957 | 26,456 | |
| Jun 01 2016 | AXSM | Axsome Therapeutic ... | Saad Mark E | Director | Option Exercise | A | 8.02 | 6,231 | 49,973 | 6,231 | |
| Jun 01 2016 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Option Exercise | A | 8.02 | 5,193 | 41,648 | 5,193 | |
| Jun 01 2016 | AXSM | Axsome Therapeutic ... | TABUTEAU HERRIOT | Chief Executive Off ... | Option Exercise | A | 8.02 | 524,000 | 4,202,480 | 524,000 | |
| Jun 01 2016 | AXSM | Axsome Therapeutic ... | Ames Constance | Vice President, Fin ... | Option Exercise | A | 8.02 | 25,000 | 200,500 | 25,000 | |
| Jun 01 2016 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 8.02 | 5,193 | 41,648 | 5,193 | |
| Dec 24 2015 | AXSM | Axsome Therapeutic ... | Kaye Randall | Chief Medical Offic ... | Buy | P | 9.03 | 1,000 | 9,026 | 6,022 | 5 K to 6 K (+19.91 %) |
| Nov 24 2015 | AXSM | Axsome Therapeutic ... | Ames Constance | Vice President, Fin ... | Option Exercise | A | 5.94 | 4,358 | 25,887 | 0 | |
| Nov 24 2015 | AXSM | Axsome Therapeutic ... | Ames Constance | Vice President, Fin ... | Buy | C | 5.94 | 4,358 | 25,887 | 4,358 | 0 to 4.4 K |
| Nov 24 2015 | AXSM | Axsome Therapeutic ... | Kaye Randall | Chief Medical Offic ... | Option Exercise | A | 5.40 | 5,022 | 27,119 | 0 | |
| Nov 24 2015 | AXSM | Axsome Therapeutic ... | Kaye Randall | Chief Medical Offic ... | Buy | C | 5.40 | 5,022 | 27,119 | 5,022 | 0 to 5 K |
| Nov 24 2015 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Option Exercise | A | 5.94 | 140,672 | 835,592 | 0 | |
| Nov 24 2015 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Option Exercise | A | 5.94 | 180,526 | 1,072,324 | 0 | |
| Nov 24 2015 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Option Exercise | A | 5.40 | 243,750 | 1,316,250 | 0 | |
| Nov 24 2015 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Buy | C | 5.94 | 140,672 | 835,592 | 647,998 | 507.3 K to 648 K (+27.73 %) |
| Nov 24 2015 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Buy | C | 5.94 | 180,526 | 1,072,324 | 507,326 | 326.8 K to 507.3 K (+55.24 %) |
| Nov 24 2015 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Buy | C | 5.40 | 243,750 | 1,316,250 | 326,800 | 83.1 K to 326.8 K (+293.50 %) |
| Nov 24 2015 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 5.94 | 4,374 | 25,982 | 0 | |
| Nov 24 2015 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | C | 5.94 | 4,374 | 25,982 | 4,374 | 0 to 4.4 K |
| Nov 24 2015 | AXSM | Axsome Therapeutic ... | Saad Mark E | Director | Option Exercise | A | 5.94 | 3,502 | 20,802 | 0 | |
| Nov 24 2015 | AXSM | Axsome Therapeutic ... | Saad Mark E | Director | Buy | C | 5.94 | 3,502 | 20,802 | 3,502 | 0 to 3.5 K |
| Nov 24 2015 | AXSM | Axsome Therapeutic ... | TABUTEAU HERRIOT | Chief Executive Off ... | Option Exercise | A | 5.94 | 7,229 | 42,940 | 0 | |
| Nov 24 2015 | AXSM | Axsome Therapeutic ... | TABUTEAU HERRIOT | Chief Executive Off ... | Buy | C | 5.94 | 7,229 | 42,940 | 7,229 | 0 to 7.2 K |
| Nov 23 2015 | AXSM | Axsome Therapeutic ... | Ames Constance | Vice President, Fin ... | Option Exercise | A | 6.47 | 40,673 | 263,154 | 40,673 | |
| Nov 23 2015 | AXSM | Axsome Therapeutic ... | Coleman Mark | Director | Option Exercise | A | 9.00 | 9,127 | 82,143 | 9,127 | |
| Nov 23 2015 | AXSM | Axsome Therapeutic ... | Saad Mark E | Director | Option Exercise | A | 9.00 | 9,127 | 82,143 | 9,127 | |
| Nov 23 2015 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 9.00 | 9,127 | 82,143 | 9,127 |
Page: 1